Multispecies emergence of dual blaKPC/NDM carbapenemase-producing Enterobacterales recovered from invasive infections in Chile
| dc.contributor.affiliation | Clinica Alemana | |
| dc.contributor.affiliation | Universidad del Desarrollo | |
| dc.contributor.affiliation | Universidad de Las Americas - Chile | |
| dc.contributor.affiliation | Universidad Andres Bello | |
| dc.contributor.affiliation | Universidad Nacional de Colombia | |
| dc.contributor.affiliation | Pontificia Universidad Catolica de Chile | |
| dc.contributor.affiliation | Walter Reed Army Institute of Research (WRAIR) | |
| dc.contributor.affiliation | United States Department of Defense | |
| dc.contributor.affiliation | United States Army | |
| dc.contributor.author | Quesille-Villalobos, Ana M. | |
| dc.contributor.author | Solar, Camila | |
| dc.contributor.author | W. Martínez, Jose R. | |
| dc.contributor.author | Rivas, Lina | |
| dc.contributor.author | Quiroz, Valeria | |
| dc.contributor.author | González, Ana M. | |
| dc.contributor.author | Riquelme-Neira, Roberto | |
| dc.contributor.author | Ugalde, Juan A. | |
| dc.contributor.author | Peters, Anne | |
| dc.contributor.author | Ortega-Recalde, Oscar | |
| dc.contributor.author | Araos, Rafael | |
| dc.contributor.author | Garcia, Patricia | |
| dc.contributor.author | Lebreton, Francois | |
| dc.contributor.author | Munita, Jose M. | |
| dc.contributor.author | Diaz, Lorena | |
| dc.date.accessioned | 2025-06-18T05:14:08Z | |
| dc.date.available | 2025-06-18T05:14:08Z | |
| dc.date.issued | 2025-01-31 | |
| dc.description.abstract | ABSTRACT Carbapenemase-producing carbapenem-resistant Enterobacterales (CP-CRE) represent a significant global threat. The emergence of dual CP-CRE is particularly alarming, as they can potentially compromise the efficacy of newer antibiotics, further decreasing therapeutic alternatives. Herein, we report the emergence of multiple species of CP-CRE recovered from invasive infections in Chile that simultaneously harbor bla KPC and bla NDM and provide an in-depth genomic characterization of these worrisome pathogens. We collected carbapenem-resistant Enterobacterales (CRE) isolates from invasive infections over a 4-year period, across 11 healthcare centers in Chile. Bacterial species and the presence of carbapenemase genes were confirmed using MALDI-TOF and PCR assays, respectively. Antimicrobial susceptibility testing was conducted through disk diffusion and broth microdilution methods. Dual CP-CRE isolates were subjected to short- and long-read whole genome sequencing to perform a detailed genomic characterization of the isolates and of the mobile genetic elements harboring the enzymes. From a total of 1,335 CRE isolates, we observed an increase in the prevalence of CP-CRE, from 11% in 2019 to 38% in 2022. A total of 11 dual CP-CRE isolates were recovered, all of them harboring bla KPC and bla NDM . Species corresponded to Escherichia coli ( n = 6), Klebsiella pneumoniae ( n = 2), Klebsiella oxytoca ( n = 2), and Citrobacter freundii ( n = 1). Dual CP-CRE isolates exhibited resistance to all tested β-lactams except for cefiderocol. The bla KPC and bla NDM encoding genes were located on independent plasmids. Platforms harboring bla KPC were diverse and included IncN, IncF, and IncFIB plasmids. In contrast, bla NDM-7 was only found on fairly conserved IncX3 plasmids. We report that a rapid increase of CP-CRE in Chile, alongside with the emergence of multiple bacterial species of CP-CRE co-harboring bla KPC-2/3 and bla NDM-7 , underscores a critical public health challenge. Our data suggest that the dissemination of bla NDM-7 was predominantly facilitated by IncX3 plasmids, whereas the spread of bla KPC involved multiple plasmid backbones. Active surveillance and genomic monitoring are critical to inform public policy and curtail the spread of these highly resistant pathogens. | |
| dc.description.sponsorship | ANID | Fondo Nacional de Desarrollo Cientfico y Tecnolgico (FONDECYT) [degrees1211947, degrees3220577, degrees3201034, degrees21231099, degrees1221209, ATE 220061]; Agencia Nacional de Investigacin y Desarrollo (ANID, Chile); This study was funded by the Agencia Nacional de Investigacion y Desarrollo (ANID, Chile) through the ANID FONDECYT REGULAR N degrees 1211947 (J.M.M), ANID FONDECYT POSTDOCTORADO N degrees 3220577 (A.M.Q.-V.), ANID FONDECYT POSTDOCTORADO N degrees 3201034 (R.R.-N.), ANID BECA DOCTORADO NACIONAL N degrees 21231099 (C.S.), ANID FONDECYT REGULAR N degrees 1221209 (J.A.U.), and ANID-Anillo ATE 220061 (R.A. and J.A.U.) | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Antimicrobial Agents and Chemotherapy, 69(1). https://doi.org/10.1128/aac.01205-24 | |
| dc.identifier.doi | https://doi.org/10.1128/aac.01205-24 | |
| dc.identifier.folio | 3201034 | |
| dc.identifier.folio | 3220577 | |
| dc.identifier.folio | 1211947 | |
| dc.identifier.folio | 21231099 | |
| dc.identifier.folio | 1221209 | |
| dc.identifier.folio | 220061 | |
| dc.identifier.issn | 0066-4804 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-7157-5026 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-7870-1056 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-9783-1956 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-6191-4792 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-6992-3407 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-1754-8123 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-8076-0346 | |
| dc.identifier.orcid | https://orcid.org/0000-0001-6638-0817 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-9733-1118 | |
| dc.identifier.pmid | 39636127 | |
| dc.identifier.researcherid | ITT-1099-2023 | |
| dc.identifier.researcherid | GLV-2034-2022 | |
| dc.identifier.researcherid | KJL-9752-2024 | |
| dc.identifier.researcherid | HZJ-5414-2023 | |
| dc.identifier.researcherid | MZR-8675-2025 | |
| dc.identifier.researcherid | AAH-5958-2020 | |
| dc.identifier.ror | https://ror.org/05y33vv83 | |
| dc.identifier.ror | https://ror.org/013kx8n09 | |
| dc.identifier.ror | https://ror.org/0166e9x11 | |
| dc.identifier.ror | https://ror.org/0198j4566 | |
| dc.identifier.ror | https://ror.org/01qq57711 | |
| dc.identifier.ror | https://ror.org/059yx9a68 | |
| dc.identifier.ror | https://ror.org/04teye511 | |
| dc.identifier.ror | https://ror.org/0145znz58 | |
| dc.identifier.scopusauthorid | 55626173100 | |
| dc.identifier.scopusauthorid | 57557358000 | |
| dc.identifier.scopusauthorid | 57418401600 | |
| dc.identifier.scopusauthorid | 55921716700 | |
| dc.identifier.scopusauthorid | 57893647200 | |
| dc.identifier.scopusauthorid | 59547221500 | |
| dc.identifier.scopusauthorid | 55787389700 | |
| dc.identifier.scopusauthorid | 36757548900 | |
| dc.identifier.scopusauthorid | 57220744660 | |
| dc.identifier.scopusauthorid | 55655358900 | |
| dc.identifier.scopusauthorid | 34976138500 | |
| dc.identifier.scopusauthorid | 59576768500 | |
| dc.identifier.scopusauthorid | 26867935000 | |
| dc.identifier.scopusauthorid | 24825037700 | |
| dc.identifier.scopusauthorid | 15135761400 | |
| dc.identifier.uri | https://repositorio.udla.cl/handle/udla/1947 | |
| dc.language.iso | eng | |
| dc.publisher | American Society for Microbiology | |
| dc.relation.funding | Fondo Nacional de Desarrollo Científico y Tecnológico, FONDECYT, (3201034, 3220577, 1211947) | |
| dc.relation.funding | Agencia Nacional de Investigación y Desarrollo, ANID, (21231099, 1221209, ATE 220061) | |
| dc.relation.funding | ANID | Fondo Nacional de Desarrollo Cientfico y Tecnolgico (FONDECYT) [degrees1211947, degrees3220577, degrees3201034, degrees21231099, degrees1221209, ATE 220061] | |
| dc.relation.funding | Agencia Nacional de Investigacin y Desarrollo (ANID, Chile) | |
| dc.relation.isindexedby | Web of Science | |
| dc.relation.issn | 0066-4804 | |
| dc.rights | Creative Commons Attribution 4.0 International | |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.source | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | |
| dc.source.uri | https://doi.org/10.1128/aac.01205-24 | |
| dc.subject | dual carbapenemase-producing CRE | |
| dc.subject | carbapenem-resistant Enterobacterales | |
| dc.subject | Enterobacterales | |
| dc.subject | antibiotic resistance | |
| dc.title | Multispecies emergence of dual blaKPC/NDM carbapenemase-producing Enterobacterales recovered from invasive infections in Chile | |
| dc.title.alternative | Multispecies emergence of dual bla KPC/NDM carbapenemase-producing Enterobacterales recovered from invasive infections in Chile | |
| dc.title.alternative | Multispecies emergence of dual blaKPC/NDM carbapenemase-producing Enterobacterales recovered from invasive infections in Chile. | |
| dc.type | journal article | |
| dc.type.coar | http://purl.org/coar/resource_type/c_6501 | |
| dc.type.driver | info:eu-repo/semantics/article | |
| oaire.citation.issue | 1 | |
| oaire.citation.title | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | |
| oaire.citation.volume | 69 | |
| oaire.fundingReference.awardNumber | 3201034 | |
| oaire.fundingReference.awardNumber | 3220577 | |
| oaire.fundingReference.awardNumber | 1211947 | |
| oaire.fundingReference.awardNumber | 21231099 | |
| oaire.fundingReference.awardNumber | 1221209 | |
| oaire.fundingReference.awardNumber | 220061 | |
| oaire.fundingReference.funderName | Agencia Nacional de Investigación y Desarrollo (ANID) | |
| udla.campus | Providencia | |
| udla.campus.adscripcion | CV | |
| udla.carrera.adscripcion | MAGÍSTER EN BIENESTAR ANIMAL Y ETOLOGÍA APLICADA | |
| udla.curacion.control | jmvg | |
| udla.escuela.adscripcion | Medicina Veterinaria | |
| udla.facultad | Facultad de Medicina Veterinaria y Agronomía | |
| udla.facultad.adscripcion | FAVA | |
| udla.facultad.codigo | FAVA | |
| udla.ods | ODS 3: Salud y bienestar | |
| udla.oecd.area | 1 Ciencias Naturales | |
| udla.oecd.discipline | 1.6.2 Microbiología | |
| udla.oecd.subarea | 1.6 Ciencias Biológicas |